Literature DB >> 9291306

Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995).

M N Mulders1, J H Reimerink, M P Koopmans, A M van Loon, H G van der Avoort.   

Abstract

Wild polioviruses were isolated a number of times in The Netherlands outside the epidemic periods (1978 and 1992-1993) from patients infected abroad, from subclinically infected persons, and from river water. Sequence comparisons revealed discrete sources of importation: the Mediterranean, India, and Indonesia. The observed wide genetic variation is indicative of repeated importation and not of indigenous circulation. Isolates identical or closely related to the epidemic type 1 strain of 1978 were found in clinical and environmental specimens until 1983, probably due to repeated importation from Turkey. Viruses related to the 1992-1993 epidemic type 3 virus had already been isolated six times before the epidemic. Of particular importance are two documented isolations of prototype wild poliovirus indistinguishable from that used to produce the inactivated vaccine. These data underscore the continued risk to the unvaccinated religious population of exposure to wild poliovirus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291306     DOI: 10.1086/514081

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in the netherlands.

Authors:  J H Reimerink; H G van der Avoort; A M van Loon; M P Koopmans
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Preventing polio from becoming a reemerging disease.

Authors:  W R Dowdle; S L Cochi; S Oberste; R Sutter
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

3.  Poliovirus containment risks and their management.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowsa; Kimberly M Thompson
Journal:  Future Virol       Date:  2018-08-10       Impact factor: 1.831

4.  GIDEON: a computer program for diagnosis, simulation, and informatics in the fields of geographic medicine and emerging diseases.

Authors:  S A Berger
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

5.  Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.

Authors:  Manish Patel; Stephen Cochi
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication Era.

Authors:  Ananda S Bandyopadhyay; Harpal Singh; Jacqueline Fournier-Caruana; John F Modlin; Jay Wenger; Jeffrey Partridge; Roland W Sutter; Michel J Zaffran
Journal:  Emerg Infect Dis       Date:  2019-07-17       Impact factor: 6.883

7.  Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Authors:  N Wurtz; A Papa; M Hukic; A Di Caro; I Leparc-Goffart; E Leroy; M P Landini; Z Sekeyova; J S Dumler; D Bădescu; N Busquets; A Calistri; C Parolin; G Palù; I Christova; M Maurin; B La Scola; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-27       Impact factor: 3.267

8.  A global call for new polio vaccines.

Authors:  David L Heymann; Roland W Sutter; R Bruce Aylward
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

9.  An economic analysis of poliovirus risk management policy options for 2013-2052.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Stephen L Cochi; Steven G F Wassilak; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-24       Impact factor: 3.090

10.  Dangerous pathogens in the laboratory: from smallpox to today's SARS setbacks and tomorrow's polio-free world.

Authors:  David L Heymann; R Bruce Aylward; Christopher Wolff
Journal:  Lancet       Date:  2004-05-15       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.